Prelude Capital Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,134	Closed	-$374K	–	1599
2024 Q2	$374K	Sell	1,134 -3,470	-75%	-$1.23M	0.03%	686
2024 Q1	$1.82M	Buy	4,604 +2,910	+172%	+$1.08M	0.12%	256
2023 Q4	$596K	Buy	+1,694	New	+$600K	0.05%	440
2021 Q3	–	Sell	-771	Closed	-$277K	–	2180
2021 Q2	$277K	Buy	+771	New	+$255K	0.02%	1235
2020 Q4	–	Sell	-152	Closed	-$42K	–	2277
2020 Q3	$42K	Buy	+152	New	+$40.2K	0.01%	1167
2020 Q2	–	Sell	-234	Closed	-$36K	–	2501
2020 Q1	$36K	Sell	234 -273	-54%	-$42K	0.01%	837
2019 Q4	$76K	Buy	507 +485	+2,205%	+$70.6K	0.01%	1201
2019 Q3	$3K	Buy	+22	New	+$3.03K	﹤0.01%	1606
2019 Q1	–	Sell	-56	Closed	-$5K	–	2349
2018 Q4	$5K	Buy	+56	New	+$6.08K	﹤0.01%	1629
2014 Q3	–	Sell	-1,011	Closed	-$43K	–	2205
2014 Q2	$43K	Sell	1,011 -555	-35%	-$23.8K	0.01%	1425
2014 Q1	$69K	Buy	+1,566	New	+$73.7K	0.01%	1172
2013 Q4	–	Sell	-160	Closed	-$7K	–	1976
2013 Q3	$7K	Buy	+160	New	+$6.1K	﹤0.01%	1382